沃华医药：董事拟减持0.44%

Core Viewpoint - The announcement from WoHua Pharmaceutical indicates that a board member and secretary, Zhang Ge, plans to reduce his shareholding in the company through a concentrated bidding process within a specified timeframe [1] Summary by Relevant Sections - Shareholding Details - Zhang Ge holds 10.0588 million shares, representing 1.74% of the company's total share capital [1] - Reduction Plan - The plan involves reducing up to 2.5147 million shares, which accounts for 0.44% of the company's total share capital [1] - The reduction will occur within three months after the announcement, starting 15 trading days post-disclosure [1] - Source of Shares - The shares to be reduced are from holdings prior to the company's initial public offering and from historical stock distributions [1] - Pricing Mechanism - The selling price for the reduced shares will be determined based on the market price at the time of sale [1]